A Phase 3 Randomized, Double Blind, Placebo-Controlled Multicenter Study Of The Analgesic Efficacy And Safety Of Tanezumab In Patients With Osteoarthritis Of The Knee.
Phase of Trial: Phase III
Latest Information Update: 10 Jul 2012
At a glance
- Drugs Tanezumab (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 10 Jul 2012 Results published in the Journal of Pain.
- 13 Jul 2010 Final patient number included based on abstract presentation at EULAR 2010.
- 19 Jun 2010 results presented at 11th Annual Congress of the European League Against Rheumatism (EULAR) 2010
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History